메뉴 건너뛰기




Volumn 24, Issue SUPPL.6, 2013, Pages

Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Author keywords

[No Author keywords available]

Indexed keywords

AMRUBICIN; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IRINOTECAN; PLATINUM COMPLEX; TOPOTECAN; VINCRISTINE;

EID: 84884566872     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt178     Document Type: Article
Times cited : (514)

References (43)
  • 2
    • 62549106168 scopus 로고    scopus 로고
    • EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
    • Sant M, Allemani C, Santiaquilani M et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-991.
    • (2009) Eur J Cancer , vol.45 , pp. 931-991
    • Sant, M.1    Allemani, C.2    Santiaquilani, M.3
  • 3
    • 33750603100 scopus 로고    scopus 로고
    • Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
    • Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006; 24: 4539-4544.
    • (2006) J Clin Oncol , vol.24 , pp. 4539-4544
    • Govindan, R.1    Page, N.2    Morgensztern, D.3
  • 4
    • 75749108918 scopus 로고    scopus 로고
    • Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis
    • Parsons A, Daley A, Begh R et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
    • (2010) BMJ , vol.340
    • Parsons, A.1    Daley, A.2    Begh, R.3
  • 5
    • 79953008247 scopus 로고    scopus 로고
    • Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers
    • Cuffe S, Moua T, Summerfield R et al. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011; 6: 818-822.
    • (2011) J Thorac Oncol , vol.6 , pp. 818-822
    • Cuffe, S.1    Moua, T.2    Summerfield, R.3
  • 6
    • 78651424752 scopus 로고    scopus 로고
    • Seventh edition of cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams
    • Lababede O, Meziane M, Rice T. Seventh edition of cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams. Chest 2011; 139: 183-189.
    • (2011) Chest , vol.139 , pp. 183-189
    • Lababede, O.1    Meziane, M.2    Rice, T.3
  • 7
    • 37349068491 scopus 로고    scopus 로고
    • The International Association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
    • Shepherd FA, Crowley J, Van Houtte P et al. The International Association for the study of lung cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007; 2: 1067-1077.
    • (2007) J Thorac Oncol , vol.2 , pp. 1067-1077
    • Shepherd, F.A.1    Crowley, J.2    Van Houtte, P.3
  • 8
    • 79960037440 scopus 로고    scopus 로고
    • The role of positron emission tomography in management of small cell lung cancer
    • Thomson D, Hulse P, Lorigan P et al. The role of positron emission tomography in management of small cell lung cancer. Lung Cancer 2011; 73: 121-126.
    • (2011) Lung Cancer , vol.73 , pp. 121-126
    • Thomson, D.1    Hulse, P.2    Lorigan, P.3
  • 10
    • 0033611522 scopus 로고    scopus 로고
    • Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
    • Turrisi AT, 3rd, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340: 265-271.
    • (1999) N Engl J Med , vol.340 , pp. 265-271
    • Turrisi, A.T.3rd.1    Kim, K.2    Blum, R.3
  • 11
    • 77649142718 scopus 로고    scopus 로고
    • Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer
    • Yu JB, Decker RH, Detterbeck FC et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010; 5: 215-219.
    • (2010) J Thorac Oncol , vol.5 , pp. 215-219
    • Yu, J.B.1    Decker, R.H.2    Detterbeck, F.C.3
  • 12
    • 77149147774 scopus 로고    scopus 로고
    • Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
    • Schreiber D, Rineer J, Weedon J et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated? Cancer 2010; 116: 1350-1357.
    • (2010) Cancer , vol.116 , pp. 1350-1357
    • Schreiber, D.1    Rineer, J.2    Weedon, J.3
  • 13
    • 84875263209 scopus 로고    scopus 로고
    • Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer
    • Reymen B, Van Loon J, van Baardwijk A et al. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer. Int J Radiat Oncol Biol Phys 2013; 85: 1319-1324.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , pp. 1319-1324
    • Reymen, B.1    Van Loon, J.2    van Baardwijk, A.3
  • 14
    • 16244389133 scopus 로고    scopus 로고
    • Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer
    • Fried DB, Morris DE, Poole C et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004; 22: 4837-4845.
    • (2004) J Clin Oncol , vol.22 , pp. 4837-4845
    • Fried, D.B.1    Morris, D.E.2    Poole, C.3
  • 15
    • 34548206333 scopus 로고    scopus 로고
    • Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
    • Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J et al. Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials. Cancer Treat Rev 2007; 33: 461-473.
    • (2007) Cancer Treat Rev , vol.33 , pp. 461-473
    • Pijls-Johannesma, M.1    De Ruysscher, D.2    Vansteenkiste, J.3
  • 16
    • 33644991074 scopus 로고    scopus 로고
    • Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
    • De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006; 24: 1057-1063.
    • (2006) J Clin Oncol , vol.24 , pp. 1057-1063
    • De Ruysscher, D.1    Pijls-Johannesma, M.2    Bentzen, S.M.3
  • 17
    • 20744445704 scopus 로고    scopus 로고
    • Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial
    • Blackstock AW, Bogart JA, Matthews C et al. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial. Clin Lung Cancer 2005; 6: 287-292.
    • (2005) Clin Lung Cancer , vol.6 , pp. 287-292
    • Blackstock, A.W.1    Bogart, J.A.2    Matthews, C.3
  • 18
    • 84881233811 scopus 로고    scopus 로고
    • Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
    • Sun JM, Ahn YC, Choi EK et al. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer. Ann Oncol 2013; 24: 2088-2092.
    • (2013) Ann Oncol , vol.24 , pp. 2088-2092
    • Sun, J.M.1    Ahn, Y.C.2    Choi, E.K.3
  • 19
    • 77951865740 scopus 로고    scopus 로고
    • Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study
    • van Loon J, De Ruysscher D, Wanders R et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010; 77: 329-336.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , pp. 329-336
    • van Loon, J.1    De Ruysscher, D.2    Wanders, R.3
  • 20
    • 83955161774 scopus 로고    scopus 로고
    • Positron emission tomography/ computed tomography-guided intensity-modulated radiotherapy for limitedstage small-cell lung cancer
    • Shirvani SM, Komaki R, Heymach JV et al. Positron emission tomography/ computed tomography-guided intensity-modulated radiotherapy for limitedstage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012; 82: e91-e97.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82
    • Shirvani, S.M.1    Komaki, R.2    Heymach, J.V.3
  • 21
    • 79955494691 scopus 로고    scopus 로고
    • Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
    • Le Péchoux C, Laplanche A, Faivre-Finn C et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol 2011; 22: 1154-1163.
    • (2011) Ann Oncol , vol.22 , pp. 1154-1163
    • Le Péchoux, C.1    Laplanche, A.2    Faivre-Finn, C.3
  • 22
    • 79961127734 scopus 로고    scopus 로고
    • Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
    • Wolfson AH, Bae K, Komak R et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 81: 77-84.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 77-84
    • Wolfson, A.H.1    Bae, K.2    Komak, R.3
  • 23
    • 79952408951 scopus 로고    scopus 로고
    • Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials
    • Foster NR, Qi Y, Shi Q et al. Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials. Cancer 2011; 117: 1262-1271.
    • (2011) Cancer , vol.117 , pp. 1262-1271
    • Foster, N.R.1    Qi, Y.2    Shi, Q.3
  • 24
    • 84863752868 scopus 로고    scopus 로고
    • Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
    • Rossi A, Di Maio M, Chiodini P et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012; 30: 1692-1698.
    • (2012) J Clin Oncol , vol.30 , pp. 1692-1698
    • Rossi, A.1    Di Maio, M.2    Chiodini, P.3
  • 25
    • 0034129381 scopus 로고    scopus 로고
    • Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatincontaining regimen versus a regimen without this alkylating agent
    • Pujol JL, Carestia L, Daurès JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatincontaining regimen versus a regimen without this alkylating agent. Br J Cancer 2000; 83: 8-15.
    • (2000) Br J Cancer , vol.83 , pp. 8-15
    • Pujol, J.L.1    Carestia, L.2    Daurès, J.P.3
  • 26
    • 0033797356 scopus 로고    scopus 로고
    • A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis
    • Mascaux C, Paesmans M, Berghmans T et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-26.
    • (2000) Lung Cancer , vol.30 , pp. 23-26
    • Mascaux, C.1    Paesmans, M.2    Berghmans, T.3
  • 27
    • 15944375520 scopus 로고    scopus 로고
    • Chemotherapy strategies in the treatment of small cell lung cancer
    • Popat S, O'Brien M. Chemotherapy strategies in the treatment of small cell lung cancer. Anticancer Drugs 2005; 16: 361-372.
    • (2005) Anticancer Drugs , vol.16 , pp. 361-372
    • Popat, S.1    O'Brien, M.2
  • 28
    • 84858322703 scopus 로고    scopus 로고
    • An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer
    • Shao N, Jin S, Zhu W. An updated meta-analysis of randomized controlled trials comparing irinotecan/platinum with etoposide/platinum in patients with previously untreated extensive-stage small cell lung cancer. J Thorac Oncol 2012; 7: 470-472.
    • (2012) J Thorac Oncol , vol.7 , pp. 470-472
    • Shao, N.1    Jin, S.2    Zhu, W.3
  • 29
    • 66349102227 scopus 로고    scopus 로고
    • Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124
    • Lara PN, Jr, Natale R, Crowley J et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009; 27: 2530-2535.
    • (2009) J Clin Oncol , vol.27 , pp. 2530-2535
    • Lara Jr., P.N.1    Natale, R.2    Crowley, J.3
  • 30
    • 77953239393 scopus 로고    scopus 로고
    • A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
    • Zatloukal P, Cardenal F, Szczesna A et al. A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease. Ann Oncol 2010; 21: 1810-1816.
    • (2010) Ann Oncol , vol.21 , pp. 1810-1816
    • Zatloukal, P.1    Cardenal, F.2    Szczesna, A.3
  • 31
    • 84865687132 scopus 로고    scopus 로고
    • Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease smallcell lung cancer: final results of a randomized phase III trial
    • Fink TH, Huber RM, Heigener DF et al. Topotecan/cisplatin compared with cisplatin/etoposide as first-line treatment for patients with extensive disease smallcell lung cancer: final results of a randomized phase III trial. J Thorac Oncol 2012; 7: 1432-1439.
    • (2012) J Thorac Oncol , vol.7 , pp. 1432-1439
    • Fink, T.H.1    Huber, R.M.2    Heigener, D.F.3
  • 32
    • 33646445762 scopus 로고    scopus 로고
    • Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer
    • Eckardt JR, von Pawel J, Papai Z et al. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer. J Clin Oncol 2006; 24: 2044-2051.
    • (2006) J Clin Oncol , vol.24 , pp. 2044-2051
    • Eckardt, J.R.1    von Pawel, J.2    Papai, Z.3
  • 33
    • 58349115184 scopus 로고    scopus 로고
    • Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
    • Lee SM, James LE, Qian W et al. Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. Thorax 2009; 64: 75-80.
    • (2009) Thorax , vol.64 , pp. 75-80
    • Lee, S.M.1    James, L.E.2    Qian, W.3
  • 34
    • 77957020019 scopus 로고    scopus 로고
    • Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis
    • Rossi A, Garassino MC, Cinquini M et al. Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis. Lung Cancer 2010; 70: 119-128.
    • (2010) Lung Cancer , vol.70 , pp. 119-128
    • Rossi, A.1    Garassino, M.C.2    Cinquini, M.3
  • 35
    • 29144480913 scopus 로고    scopus 로고
    • Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A meta-analysis of the published controlled trials
    • Bozcuk H, Artac M, Ozdogan M et al. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A meta-analysis of the published controlled trials. Cancer 2005; 104: 2650-2657.
    • (2005) Cancer , vol.104 , pp. 2650-2657
    • Bozcuk, H.1    Artac, M.2    Ozdogan, M.3
  • 36
    • 34547937885 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in small-cell lung cancer
    • Slotman BJ, Faivre-Finn C, Kramer GW et al. Prophylactic cranial irradiation in small-cell lung cancer. N Engl J Med 2007; 357: 664-672.
    • (2007) N Engl J Med , vol.357 , pp. 664-672
    • Slotman, B.J.1    Faivre-Finn, C.2    Kramer, G.W.3
  • 37
    • 58149346191 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups
    • Slotman BJ, Mauer ME, Bottomley A et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009; 27: 78-84.
    • (2009) J Clin Oncol , vol.27 , pp. 78-84
    • Slotman, B.J.1    Mauer, M.E.2    Bottomley, A.3
  • 38
    • 0033016449 scopus 로고    scopus 로고
    • Role of radiation therapy in the combinedmodality treatment of patients with extensive disease small-cell lung cancer: a randomized study
    • Jeremic B, Shibamoto Y, Nikolic N et al. Role of radiation therapy in the combinedmodality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999; 17: 2092-2099.
    • (1999) J Clin Oncol , vol.17 , pp. 2092-2099
    • Jeremic, B.1    Shibamoto, Y.2    Nikolic, N.3
  • 39
    • 34247218552 scopus 로고    scopus 로고
    • Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
    • O'Brien ME, Ciuleanu TE, Tsekov H et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006; 24: 5441-5447.
    • (2006) J Clin Oncol , vol.24 , pp. 5441-5447
    • O'Brien, M.E.1    Ciuleanu, T.E.2    Tsekov, H.3
  • 40
    • 0033044111 scopus 로고    scopus 로고
    • Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
    • von Pawel J, Schiller JH, Shepherd FA et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999; 1 and 427: 658-667.
    • (1999) J Clin Oncol , vol.1 , pp. 658-667
    • von Pawel, J.1    Schiller, J.H.2    Shepherd, F.A.3
  • 41
    • 34249941781 scopus 로고    scopus 로고
    • Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
    • Eckardt JR, von Pawel J, Pujol JL et al. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. Clin Oncol 2007; 25: 2086-2092.
    • (2007) Clin Oncol , vol.25 , pp. 2086-2092
    • Eckardt, J.R.1    von Pawel, J.2    Pujol, J.L.3
  • 42
    • 80051845520 scopus 로고    scopus 로고
    • Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC)
    • abstr 7000
    • Jotte R, Von Pawel J, Spigel D et al. Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC). J Clin Oncol 2012; 29 (Suppl.): abstr 7000.
    • (2012) J Clin Oncol , vol.29 , Issue.SUPPL.
    • Jotte, R.1    Von Pawel, J.2    Spigel, D.3
  • 43
    • 38649126178 scopus 로고    scopus 로고
    • Effectiveness of intensive follow-up after response in patients with small cell lung cancer
    • Sugiyama T, Hirose T, Hosaka T et al. Effectiveness of intensive follow-up after response in patients with small cell lung cancer. Lung Cancer 2008; 59: 255-261.
    • (2008) Lung Cancer , vol.59 , pp. 255-261
    • Sugiyama, T.1    Hirose, T.2    Hosaka, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.